Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaHGH Fragment 176-191

HGH Fragment 176-191

Growth-hormone fragment

Not ARTG-approved

What it is

A fragment of growth hormone marketed for fat loss; closely related to AOD-9604.

What the evidence shows

Despite metabolic interest, it has not been established as an effective, approved weight-loss medicine.

Safety & reported risks

Unregulated supply with unknown quality; marketing typically outpaces the evidence.

Status in Australia

Not ARTG-approved as a medicine. The marketed fat-loss framing is not supported by registration.

How it’s lawfully accessed

No approved medicine pathway. Online supply is not lawful for human use.

Related peptides

AOD-9604Growth-hormone fragmentNot ARTG-approvedSomatropinRecombinant human growth hormonePrescription medicine

Sources & further reading

This entry is general information about HGH Fragment 176-191, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.